Franceschi, E.* et al. EANO–EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol. 20, e715-e728 (2019)
Psallidas, I.* et al. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): A multicohort analysis. Lancet Oncol. 19, 930-939 (2018)
Guinney, J.* et al. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: Development of a prognostic model through a crowdsourced challenge with open clinical trial data. Lancet Oncol. 18, 132-142 (2017)
Pastore, A.* et al. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: A retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 16, 1111-1122 (2015)
Issels, R.D. et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 11, 561-570 (2010)
Landi, M.T.* et al. GPC5 rs2352028 variant and risk of lung cancer in never smokers. Lancet Oncol. 11, 714-716 (2010)